Diobex, Inc
Company Information
San Francisco, CA
United States
Phone: 1 415 551 0400
Fax: 1 415 551 4113
Overview
DiObex, Inc., a clinical-stage company based in San Francisco, is developing unique, first-in-class therapies for the critically under-served metabolic disease market. Our pipeline products address the markets for the treatment of type 1 diabetes, type 2 diabetes and its co-morbidities such as hypertension, dyslipidemia and visceral adiposity (often referred to collectively as metabolic syndrome ). Obesity is an additional therapeutic focus for the company. DiObex is currently focused on the following two clinical development programs:
Corporate Structure
CHIEF EXECUTIVE OFFICER
TOP EXECUTIVES
Daniel Green President
Bernice Welles Vice President, Development
Jerrold M Olefsky Head of the Division of Endocrinology and Metaboli
Bruce W Carlson Vice President and Chief Financial Officer
Timothy A Stewart Vice President, Research
Robert R Henry Chairman of Scientific Advisory Board
Robert A Rizza Board of Directors
Patrick G. Enright Board of Directors
Fred Volinsky Consultant
Harold E. Selick Board of Directors
Walter Olesiak Board of Directors
Peter Van Vlasselaer Board of Directors
Eckard Weber Board Member
Michael F. Powell Board of Directors
Daniel J Drucker Board of Directors
Keith A Vendola Senior Director, Corporate Development
Gunnar Weikert Board of Directors
Robert S Sherwin Board of Directors
Lester L Lien Board of Directors
Erika Lum Copyright Agent
Glenn M Chertow Board of Directors
John D Baxter Board of Directors
